論文・技術情報追加のお知らせ

①Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database.

免疫チェックポイント阻害剤と肝障害のシグナル評価

対象DB：FAERS

②Pantoprazole associated dyspepsia hypocalcemia and hyponatremia: A disproportionality analysis in FDA adverse event reporting system (FAERS) database.

パントプラゾールの新規有害事象解析研究

対象DB：FAERS

③Reports of Guillain-Barre Syndrome After COVID-19 Vaccination in the United States.

ギラン・バレー症候群患者のCOVID-19ワクチン接種後の報告パターン比較

対象DB：VAERS

④Disproportionality analysis of quinolone safety in children using data from the FDA adverse event reporting system (FAERS).

小児におけるキノロン系抗菌薬の有害事象安全性プロファイル研究

対象DB：FAERS

⑤Platinum drugs-related safety profile: The latest five-year analysis from FDA adverse event reporting system data.

白金製剤3剤の有害事象シグナル探索研究

対象DB：FAERS

⑥Hemorrhagic and thrombotic adverse events associated with emicizumab and extended half-life factor VIII replacement drugs: EudraVigilance data of 2021.

エミシズマブとバイパス製剤に関連する出血性および血栓性の有害事象報告率評価

対象DB：EudraVigilance